Bendroflumethiazide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 2 USDMF, 2 CEP/COS, 2 EU WC, 2 NDC API, 4 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 9 FDA Orange Book, 12 Europe, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 2 DKSH, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

56 Fillers, Diluents & Binders, 35 Coating Systems & Additives, 27 Direct Compression, 21 Disintegrants & Superdisintegrants, 19 Granulation, 18 Chewable & Orodispersible Aids, 16 Taste Masking, 15 Controlled & Modified Release, 13 Thickeners and Stabilizers, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 5 Rheology Modifiers, 5 Parenteral, 5 Empty Capsules, 4 Film Formers & Plasticizers, 4 Vegetarian Capsules, 3 API Stability Enhancers, 2 Coloring Agents, 2 Solubilizers, 2 Emulsifying Agents

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices

2 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 18647 / DOSAGE - TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BENDROFLUMETHIAZIDE(UNII: 5Q52X6ICJI) (BENDROFLUMETHIAZIDE - UNII:5Q52X6ICJI)	BENDROFLUMETHIAZIDE	5mg \| 5mg
NADOLOL(UNII: FEN504330V) (NADOLOL - UNII:FEN504330V)	NADOLOL	40mg \| 80mg

Inactive Ingredients

Ingredient Name	Pfizer Laboratories Div Pfizer Inc
FD&C BLUE NO. 2(L06K8R7DQK)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POVIDONE, UNSPECIFIED(FZ989GH94E)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)

Setid 3f11df27 710b 4903 A985 74ee4674a844 Applno 18647 Form Tablet Oral Dosage 5mg 80mg - Drug Product Composition: Bendroflumethiazide